These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 22973049)
21. Chimeric RXFP1 and RXFP2 Receptors Highlight the Similar Mechanism of Activation Utilizing Their N-Terminal Low-Density Lipoprotein Class A Modules. Bruell S; Kong RC; Petrie EJ; Hoare B; Wade JD; Scott DJ; Gooley PR; Bathgate RA Front Endocrinol (Lausanne); 2013; 4():171. PubMed ID: 24273532 [TBL] [Abstract][Full Text] [Related]
22. Negative cooperativity in H2 relaxin binding to a dimeric relaxin family peptide receptor 1. Svendsen AM; Zalesko A; Kønig J; Vrecl M; Heding A; Kristensen JB; Wade JD; Bathgate RA; De Meyts P; Nøhr J Mol Cell Endocrinol; 2008 Dec; 296(1-2):10-7. PubMed ID: 18723073 [TBL] [Abstract][Full Text] [Related]
23. International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides. Halls ML; Bathgate RA; Sutton SW; Dschietzig TB; Summers RJ Pharmacol Rev; 2015; 67(2):389-440. PubMed ID: 25761609 [TBL] [Abstract][Full Text] [Related]
24. Role of the intra-A-chain disulfide bond of insulin-like peptide 3 in binding and activation of its receptor, RXFP2. Zhang S; Hughes RA; Bathgate RA; Shabanpoor F; Hossain MA; Lin F; van Lierop B; Robinson AJ; Wade JD Peptides; 2010 Sep; 31(9):1730-6. PubMed ID: 20570702 [TBL] [Abstract][Full Text] [Related]
25. Receptors for relaxin family peptides. Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ Ann N Y Acad Sci; 2005 May; 1041():61-76. PubMed ID: 15956688 [TBL] [Abstract][Full Text] [Related]
26. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides. Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ Pharmacol Rev; 2006 Mar; 58(1):7-31. PubMed ID: 16507880 [TBL] [Abstract][Full Text] [Related]
27. Structure and activity in the relaxin family of peptides. Tregear GW; Bathgate RA; Hossain MA; Lin F; Zhang S; Shabanpoor F; Scott DJ; Ma S; Gundlach AL; Samuel CS; Wade JD Ann N Y Acad Sci; 2009 Apr; 1160():5-10. PubMed ID: 19416150 [TBL] [Abstract][Full Text] [Related]
28. Identification of the N-linked glycosylation sites of the human relaxin receptor and effect of glycosylation on receptor function. Yan Y; Scott DJ; Wilkinson TN; Ji J; Tregear GW; Bathgate RA Biochemistry; 2008 Jul; 47(26):6953-68. PubMed ID: 18533687 [TBL] [Abstract][Full Text] [Related]
29. The relaxin receptor (RXFP1) utilizes hydrophobic moieties on a signaling surface of its N-terminal low density lipoprotein class A module to mediate receptor activation. Kong RC; Petrie EJ; Mohanty B; Ling J; Lee JC; Gooley PR; Bathgate RA J Biol Chem; 2013 Sep; 288(39):28138-51. PubMed ID: 23926099 [TBL] [Abstract][Full Text] [Related]
30. Application of the novel bioluminescent ligand-receptor binding assay to relaxin-RXFP1 system for interaction studies. Wu QP; Zhang L; Shao XX; Wang JH; Gao Y; Xu ZG; Liu YL; Guo ZY Amino Acids; 2016 Apr; 48(4):1099-1107. PubMed ID: 26767372 [TBL] [Abstract][Full Text] [Related]
31. Dimerization and negative cooperativity in the relaxin family peptide receptors. Svendsen AM; Vrecl M; Knudsen L; Heding A; Wade JD; Bathgate RA; De Meyts P; Nøhr J Ann N Y Acad Sci; 2009 Apr; 1160():54-9. PubMed ID: 19416159 [TBL] [Abstract][Full Text] [Related]
32. Defining the LGR8 residues involved in binding insulin-like peptide 3. Scott DJ; Wilkinson TN; Zhang S; Ferraro T; Wade JD; Tregear GW; Bathgate RA Mol Endocrinol; 2007 Jul; 21(7):1699-712. PubMed ID: 17473281 [TBL] [Abstract][Full Text] [Related]
33. Mapping key regions of the RXFP2 low-density lipoprotein class-A module that are involved in signal activation. Kong RC; Bathgate RA; Bruell S; Wade JD; Gooley PR; Petrie EJ Biochemistry; 2014 Jul; 53(28):4537-48. PubMed ID: 24983702 [TBL] [Abstract][Full Text] [Related]
34. Cooperative binding of insulin-like Peptide 3 to a dimeric relaxin family peptide receptor 2. Svendsen AM; Vrecl M; Ellis TM; Heding A; Kristensen JB; Wade JD; Bathgate RA; De Meyts P; Nøhr J Endocrinology; 2008 Mar; 149(3):1113-20. PubMed ID: 18063691 [TBL] [Abstract][Full Text] [Related]
35. The electrostatic interactions of relaxin-3 with receptor RXFP4 and the influence of its B-chain C-terminal conformation. Wang XY; Guo YQ; Zhang WJ; Shao XX; Liu YL; Xu ZG; Guo ZY FEBS J; 2014 Jul; 281(13):2927-36. PubMed ID: 24802387 [TBL] [Abstract][Full Text] [Related]
36. Recombinant RXFP1-LDL-A module does not form dimers. Petrie EJ; Periguini MA; Bathgate RA; Gooley PR Ital J Anat Embryol; 2013; 118(1 Suppl):4-6. PubMed ID: 24640556 [TBL] [Abstract][Full Text] [Related]
37. Synthesis of fluorescent analogs of relaxin family peptides and their preliminary in vitro and in vivo characterization. Chan LJ; Smith CM; Chua BE; Lin F; Bathgate RA; Separovic F; Gundlach AL; Hossain MA; Wade JD Front Chem; 2013; 1():30. PubMed ID: 24790958 [TBL] [Abstract][Full Text] [Related]
38. Real-time examination of cAMP activity at relaxin family peptide receptors using a BRET-based biosensor. Valkovic AL; Leckey MB; Whitehead AR; Hossain MA; Inoue A; Kocan M; Bathgate RAD Pharmacol Res Perspect; 2018 Oct; 6(5):e00432. PubMed ID: 30263124 [TBL] [Abstract][Full Text] [Related]
39. Relaxin-Family Peptide Receptors 1 and 2 Are Fully Functional in the Bovine. Dai Y; Ivell R; Liu X; Janowski D; Anand-Ivell R Front Physiol; 2017; 8():359. PubMed ID: 28634453 [TBL] [Abstract][Full Text] [Related]
40. Design and development of analogues of dimers of insulin-like peptide 3 B-chain as high-affinity antagonists of the RXFP2 receptor. Shabanpoor F; Zhang S; Hughes RA; Hossain MA; Layfield S; Ferraro T; Bathgate RA; Separovic F; Wade JD Biopolymers; 2011; 96(1):81-7. PubMed ID: 20560146 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]